MIZUHO FINANCIAL GROUP Stock Forum

CNBC’s Jim Cramer said today’s market presents a rare landscape where analyst upgrades and price target bumps are catalysts for market action.
“These recommendations and little tidbits and asides suddenly have power in this market because, at the moment, there doesn’t seem to be anything about what we call ‘resistance,’” he said, “Meaning there’s nothing stopping stocks from going higher: not the bond market, not the Fed, not ...

Anthony's extensive research knowledge and partnership across leading medical devices, therapeutics and diagnostic companies are going to enhance Mizuho's global healthcare offering according to Susan Gilbertson, Head of US Equity Research at Mizuho Americas.